PUBLIC - Croatia, the War, and the Future
PUBLIC - Croatia, the War, and the Future
PUBLIC - Croatia, the War, and the Future
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Efectin ER capsules 37.5<br />
mg<br />
Efectin ER capsules 75 mg<br />
Efferalgan 1 g effervescent<br />
tablets<br />
Efferalgan 150 mg<br />
suppositories<br />
Efferalgan 300 mg<br />
suppositories<br />
EFFERALGAN 500 mg,<br />
effervescent tablets<br />
Efferalgan 80 mg<br />
suppositories<br />
Efferalgan solution for<br />
children<br />
EFFERALGAN plus<br />
vitamin C, effervescent<br />
tablets<br />
Efflumidex Liquifilm eye<br />
drops<br />
prolonged-release<br />
capsules<br />
prolonged release<br />
capsules<br />
effervescent tablets<br />
suppositories<br />
suppositories<br />
effervescent tablets<br />
suppositories<br />
solution for oral use<br />
effervescent tablets<br />
eye drops, suspension<br />
EFOX tablets 250 mg film coated tablets<br />
Efox tablets 500 mg film coated tablets<br />
Eglonyl 100 mg/2 mL<br />
solution for injection<br />
Eglonyl 25 mg/5 mL oral<br />
solution<br />
solution for injection<br />
oral solution<br />
Wyeth Medica<br />
Republic of Irel<strong>and</strong>,<br />
Newbridge, Republic of<br />
Irel<strong>and</strong><br />
Wyeth Medica<br />
Republic of Irel<strong>and</strong>,<br />
Newbridge, Republic of<br />
Irel<strong>and</strong><br />
Bristol-Myers Squibb,<br />
304, avenue du Dr.<br />
Jean Bru, Agen,<br />
France; Bristol-Myers<br />
Squibb, 979 Avenue<br />
des Pyrenees, Le<br />
Passage, France<br />
Bristol-Myers Squibb,<br />
304, avenue du Dr<br />
Jean Bru, Agen,<br />
France<br />
Bristol-Myers Squibb,<br />
304, avenue du Dr<br />
Jean Bru, Agen,<br />
France<br />
Bristol-Myers Squibb,<br />
304, avenue du Dr<br />
Jean Bru, Agen,<br />
France i Bristol-Myers<br />
Squibb, 979 Avenue<br />
des Pyrénés, Le<br />
Passage, France<br />
Bristol-Myers Squibb,<br />
304, avenue du Dr<br />
Jean Bru, Agen,<br />
France<br />
Bristol-Myers Squibb,<br />
304, avenue du Dr<br />
Jean Bru, Agen,<br />
France<br />
Bristol-Myers Squibb,<br />
304, avenue du Dr.<br />
Jean Bru, Agen,<br />
France; Bristol-Myers<br />
Squibb, 979 Avenue<br />
des Pyrenees, Le<br />
Passage, France<br />
Allergan<br />
Pharmaceuticals<br />
Republic of Irel<strong>and</strong>,<br />
Castlebar Road,<br />
Westport, Co Mayo,<br />
Republic of Irel<strong>and</strong><br />
Farmal d.d., Branitelja<br />
domovinskog rata 8,<br />
Ludbreg, Republic of<br />
<strong>Croatia</strong><br />
Farmal d.d., Branitelja<br />
domovinskog rata 8,<br />
Ludbreg, Republic of<br />
<strong>Croatia</strong><br />
Alkaloid AD-Skopje,<br />
Skopje, FYROM in<br />
cooperation with<br />
Sanofi-Aventis, France<br />
Alkaloid AD-Skopje,<br />
Skopje, FYROM in<br />
cooperation with<br />
Sanofi-Aventis, France<br />
Box with 30 capsules (blister,<br />
3x10 capsules)<br />
Box with 28 capsules (blister,<br />
2x14 capsules)<br />
8 effervescent tablets in a<br />
plastic tube, supplied in a<br />
box<br />
10 (2x5) suppositories in a<br />
PVC/PE strip, supplied in a<br />
box<br />
10 (2x5) suppositories in a<br />
PVC/PE strip, supplied in a<br />
box<br />
16 (4x4) effervescent tablets<br />
in a strip (Al/PE), supplied in<br />
a box<br />
10 (2x5) suppositories in a<br />
PVC/PE strip, supplied in a<br />
box<br />
90 mL of solution in a brown<br />
plastic bottle with a temper-<br />
evident stopper, supplied in a<br />
box<br />
10 effervescent tablets in a<br />
polypropylene tube, supplied<br />
in a box<br />
5 mL of suspension in a<br />
plastic bottle with a dropper,<br />
supplied in a box<br />
10 (1x10) tablets in a Al/Al<br />
blister, supplied in a box<br />
10 (1x10) tablets in a Al/Al<br />
blister, supplied in a box<br />
30 colourless glass<br />
ampoules each containing 2<br />
mL of solution, supplied in a<br />
box<br />
120 mL of solution in an<br />
amber glass botlle with<br />
dispenser, supplied in a box<br />
YES YES<br />
YES YES<br />
YES YES YES<br />
YES YES YES<br />
YES YES YES<br />
YES YES YES<br />
YES YES YES<br />
YES YES YES<br />
YES YES YES<br />
YES YES<br />
YES YES<br />
YES YES<br />
YES YES<br />
YES YES<br />
14509/11 WS/jj 273<br />
ANNEX II DGF 2A / DG K 2 EN
Change language